Aprea Therapeutics (APRE) Stock Forecast, Price Target & Predictions
APRE Stock Forecast
Aprea Therapeutics stock forecast is as follows: a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
APRE Analyst Ratings
Buy
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Mar 10, 2023 | Loop Capital Markets | Buy | Initialise | |
Mar 10, 2023 | Citigroup | Buy | Initialise | |
Mar 10, 2023 | RBC Capital | Outperform | Initialise | |
Mar 10, 2023 | Cowen & Co. | Market Perform | Initialise | |
Mar 10, 2023 | UBS | Sell | Initialise | |
Jul 08, 2022 | Wedbush | Outperform | Initialise | |
Dec 29, 2020 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Aprea Therapeutics Financial Forecast
Aprea Therapeutics Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | $225.00K | $225.00K | $50.00K | $165.00K | $125.00K |
High Forecast | - | - | - | - | $225.00K | $225.00K | $50.00K | $165.00K | $125.00K |
Low Forecast | - | - | - | - | $225.00K | $225.00K | $50.00K | $165.00K | $125.00K |
# Analysts | - | - | - | - | 1 | 1 | 1 | 2 | 1 |
Surprise % | - | - | - | - | - | - | - | - | - |
Forecast
Aprea Therapeutics EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 1 | 1 | 1 | 2 | 1 |
EBITDA | - | - | - | - | - | - | - | - | $-3.52M |
Avg Forecast | - | - | - | - | $135.00K | $135.00K | $30.00K | $99.00K | $75.00K |
High Forecast | - | - | - | - | $135.00K | $135.00K | $30.00K | $99.00K | $75.00K |
Low Forecast | - | - | - | - | $135.00K | $135.00K | $30.00K | $99.00K | $75.00K |
Surprise % | - | - | - | - | - | - | - | - | -46.97% |
Forecast
Aprea Therapeutics Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 1 | 1 | 1 | 2 | 1 |
Net Income | - | - | - | - | - | - | - | - | $-3.20M |
Avg Forecast | $-2.64M | $-2.52M | $-2.32M | $-4.10M | $-3.92M | $-4.26M | $-3.66M | $-4.55M | $-6.69M |
High Forecast | $-2.64M | $-2.52M | $-2.32M | $-4.10M | $-3.11M | $-4.26M | $-3.66M | $-1.55M | $-6.69M |
Low Forecast | $-2.64M | $-2.52M | $-2.32M | $-4.10M | $-4.67M | $-4.26M | $-3.66M | $-7.56M | $-6.69M |
Surprise % | - | - | - | - | - | - | - | - | 0.48% |
Forecast
Aprea Therapeutics SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 1 | 1 | 1 | 2 | 1 |
SG&A | - | - | - | - | - | - | - | - | $1.72M |
Avg Forecast | - | - | - | - | $829.71K | $829.71K | $184.38K | $608.45K | $460.95K |
High Forecast | - | - | - | - | $829.71K | $829.71K | $184.38K | $608.45K | $460.95K |
Low Forecast | - | - | - | - | $829.71K | $829.71K | $184.38K | $608.45K | $460.95K |
Surprise % | - | - | - | - | - | - | - | - | 3.73% |
Forecast
Aprea Therapeutics EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 1 | 1 | 1 | 2 | 1 |
EPS | - | - | - | - | - | - | - | - | $-0.86 |
Avg Forecast | $-0.45 | $-0.42 | $-0.39 | $-0.69 | $-0.66 | $-0.72 | $-0.62 | $-0.77 | $-1.13 |
High Forecast | $-0.45 | $-0.42 | $-0.39 | $-0.69 | $-0.52 | $-0.72 | $-0.62 | $-0.26 | $-1.13 |
Low Forecast | $-0.45 | $-0.42 | $-0.39 | $-0.69 | $-0.79 | $-0.72 | $-0.62 | $-1.27 | $-1.13 |
Surprise % | - | - | - | - | - | - | - | - | 0.76% |
Forecast
Aprea Therapeutics Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ANEB | Anebulo Pharmaceuticals | $1.31 | $6.00 | 358.02% | Buy |
LUMO | Lumos Pharma | $4.34 | $16.50 | 280.18% | Buy |
ACRV | Acrivon Therapeutics | $7.21 | $22.50 | 212.07% | Buy |
ANAB | AnaptysBio | $15.99 | $49.83 | 211.63% | Buy |
MLYS | Mineralys Therapeutics | $12.35 | $30.00 | 142.91% | Buy |
ADAG | Adagene | $2.10 | $5.00 | 138.10% | Buy |
RZLT | Rezolute | $4.44 | $6.67 | 50.23% | Buy |
APRE | Aprea Therapeutics | $3.34 | $3.00 | -10.18% | Buy |
IKNA | Ikena Oncology | $1.62 | $1.33 | -17.90% | Buy |